Cargando…
Tumor immunogenomic signatures improve a prognostic model of melanoma survival
BACKGROUND: Tumor mutation burden (TMB) has been associated with melanoma immunotherapy (IT) outcomes, including survival. We explored whether combining TMB with immunogenomic signatures recently identified by The Cancer Genome Atlas (TCGA) can refine melanoma prognostic models of overall survival (...
Autores principales: | Morales, Leah, Simpson, Danny, Ferguson, Robert, Cadley, John, Esteva, Eduardo, Monson, Kelsey, Chat, Vylyny, Martinez, Carlos, Weber, Jeffrey, Osman, Iman, Kirchhoff, Tomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888085/ https://www.ncbi.nlm.nih.gov/pubmed/33596955 http://dx.doi.org/10.1186/s12967-021-02738-0 |
Ejemplares similares
-
Correction: Tumor immunogenomic signatures improve a prognostic model of melanoma survival
por: Morales, Leah, et al.
Publicado: (2023) -
A genome-wide association study of germline variation and melanoma prognosis
por: Chat, Vylyny, et al.
Publicado: (2023) -
Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM)
por: Ferguson, Robert, et al.
Publicado: (2019) -
Ultra Low-Coverage Whole-Genome Sequencing as an Alternative to Genotyping Arrays in Genome-Wide Association Studies
por: Chat, Vylyny, et al.
Publicado: (2022) -
Germline genetic host factors as predictive biomarkers in immuno-oncology
por: Chat, Vylyny, et al.
Publicado: (2019)